Literature DB >> 18323768

Psychophysical and neurochemical abnormalities of pain processing in fibromyalgia.

Roland Staud1, Michael Spaeth.   

Abstract

Fibromyalgia pain is frequent in the general population, but its pathogenesis is only partially understood. Patients with fibromyalgia lack consistent tissue abnormalities but display features of hyperalgesia (increased sensitivity to painful stimuli) and allodynia (lowered pain threshold). Many recent fibromyalgia studies have demonstrated central nervous system (CNS) pain processing abnormalities, including abnormal temporal summation of pain. In the CNS, persistent nociceptive input from peripheral tissues can lead to neuroplastic changes resulting in central sensitization and pain. This mechanism appears to represent a hallmark of fibromyalgia and many other chronic pain syndromes, including irritable bowel syndrome, temporomandibular disorder, migraine, and low back pain. Importantly, after central sensitization has been established, only minimal peripheral input is required for the maintenance of the chronic pain state. Additional factors, including pain-related negative affect and poor sleep have been shown to significantly contribute to clinical fibromyalgia pain. Better understanding of these mechanisms and their relationship to central sensitization and clinical pain will provide new approaches for the prevention and treatment of fibromyalgia and other chronic pain syndromes.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18323768     DOI: 10.1017/s109285290002678x

Source DB:  PubMed          Journal:  CNS Spectr        ISSN: 1092-8529            Impact factor:   3.790


  22 in total

1.  Pain variability in fibromyalgia is related to activity and rest: role of peripheral tissue impulse input.

Authors:  Roland Staud; Michael E Robinson; Elizabeth E Weyl; Donald D Price
Journal:  J Pain       Date:  2010-05-07       Impact factor: 5.820

Review 2.  Central pain mechanisms in chronic pain states--maybe it is all in their head.

Authors:  Kristine Phillips; Daniel J Clauw
Journal:  Best Pract Res Clin Rheumatol       Date:  2011-04       Impact factor: 4.098

Review 3.  The role of sleep in pain and fibromyalgia.

Authors:  Ernest H S Choy
Journal:  Nat Rev Rheumatol       Date:  2015-04-28       Impact factor: 20.543

Review 4.  Advances in the assessment of fibromyalgia.

Authors:  David A Williams; Stephen Schilling
Journal:  Rheum Dis Clin North Am       Date:  2009-05       Impact factor: 2.670

5.  Alterations in pain responses in treated and untreated patients with restless legs syndrome: associations with sleep disruption.

Authors:  Robert R Edwards; Phillip J Quartana; Richard P Allen; Seth Greenbaum; Christopher J Earley; Michael T Smith
Journal:  Sleep Med       Date:  2011-05-12       Impact factor: 3.492

6.  Investigation of central pain processing in shoulder pain: converging results from 2 musculoskeletal pain models.

Authors:  Carolina Valencia; Lindsay L Kindler; Roger B Fillingim; Steven Z George
Journal:  J Pain       Date:  2012-01       Impact factor: 5.820

Review 7.  Fibromyalgia: from pathophysiology to therapy.

Authors:  Tobias Schmidt-Wilcke; Daniel J Clauw
Journal:  Nat Rev Rheumatol       Date:  2011-07-19       Impact factor: 20.543

8.  Milnacipran: a selective serotonin and norepinephrine dual reuptake inhibitor for the management of fibromyalgia.

Authors:  Robert H Palmer; Antonia Periclou; Pradeep Banerjee
Journal:  Ther Adv Musculoskelet Dis       Date:  2010-08       Impact factor: 5.346

9.  Fibromyalgia: From treatment to rehabilitation.

Authors:  Marta Imamura; David A Cassius; Felipe Fregni
Journal:  Eur J Pain       Date:  2009-11-01       Impact factor: 3.931

10.  Investigation of central pain processing in postoperative shoulder pain and disability.

Authors:  Carolina Valencia; Roger B Fillingim; Mark Bishop; Samuel S Wu; Thomas W Wright; Michael Moser; Kevin Farmer; Steven Z George
Journal:  Clin J Pain       Date:  2014-09       Impact factor: 3.442

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.